Unified classification and risk-stratification in Acute Myeloid Leukemia

Yanis Tazi; Juan E. Arango-Ossa; Yangyu Zhou; Elsa Bernard; Ian Thomas; Amanda Gilkes; Sylvie Freeman; Yoann Pradat; Sean J Johnson; Robert Hills; Richard Dillon; Max F Levine; Daniel Leongamornlert; Adam Butler; Arnold Ganser; Lars Bullinger; Konstanze Döhner; Oliver Ottmann; Richard Adams; Hartmut Döhner; Peter J Campbell; Alan K Burnett; Michael Dennis; Nigel H Russell; Sean M. Devlin; Brian J P Huntly; Elli Papaemmanuil

doi:10.1101/2022.03.09.22271087

Unified classification and risk-stratification in Acute Myeloid Leukemia

View ORCID ProfileYanis Tazi, Juan E. Arango-Ossa, Yangyu Zhou, View ORCID ProfileElsa Bernard, Ian Thomas, Amanda Gilkes, Sylvie Freeman, Yoann Pradat, Sean J Johnson, Robert Hills, Richard Dillon, Max F Levine, Daniel Leongamornlert, Adam Butler, Arnold Ganser, Lars Bullinger, Konstanze Döhner, Oliver Ottmann, Richard Adams, Hartmut Döhner, Peter J Campbell, Alan K Burnett, Michael Dennis, Nigel H Russell, Sean M. Devlin, View ORCID ProfileBrian J P Huntly, Elli Papaemmanuil

doi: https://doi.org/10.1101/2022.03.09.22271087

Yanis Tazi

1Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA

2Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA

3Tri-Institutional Computational Biology and Medicine PhD Program, Weill Cornell Medicine of Cornell University and Rockefeller University, New York, NY, USA

4The Rockefeller University, New York, NY, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Yanis Tazi

Juan E. Arango-Ossa

1Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA

2Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Yangyu Zhou

1Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA

2Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Elsa Bernard

1Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA

2Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA

PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Elsa Bernard

Ian Thomas

5Centre for Trials Research, School of Medicine, Cardiff University, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Amanda Gilkes

6Department of Haematology, School of Medicine, Cardiff University, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sylvie Freeman

7Institute of Immunology and Immunotherapy, University of Birmingham, UK

MD. DPhil

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Yoann Pradat

1Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sean J Johnson

5Centre for Trials Research, School of Medicine, Cardiff University, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Robert Hills

8Nuffield Department of Population Health, University of Oxford, Oxford, UK

DPhil

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Richard Dillon

9Department of Medical and Molecular Genetics, King’s College, London, UK

PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Max F Levine

1Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Daniel Leongamornlert

10Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, UK

PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Adam Butler

10Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Arnold Ganser

11Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lars Bullinger

12Department of Hematology, Oncology, and Tumorimmunology, Campus Virchow Klinikum, Berlin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Konstanze Döhner

13Department of Internal Medicine III, Ulm University, Ulm, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Oliver Ottmann

6Department of Haematology, School of Medicine, Cardiff University, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Richard Adams

5Centre for Trials Research, School of Medicine, Cardiff University, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Hartmut Döhner

13Department of Internal Medicine III, Ulm University, Ulm, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Peter J Campbell

10Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, UK

MD PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Alan K Burnett

14Visiting Professor University of Glasgow, formerly Cardiff University, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michael Dennis

15The Christie NHS Foundation Trust, Manchester, U.K.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Nigel H Russell

16Department of Haematology, Nottingham University Hospital, Nottingham, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sean M. Devlin

1Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA

PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Brian J P Huntly

17Department of Haematology and Wellcome Trust-MRC Cambridge Stem Cell Institute, University of Cambridge, UK

MD. PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Brian J P Huntly

Elli Papaemmanuil

1Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA

2Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA

PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: papaemme@mskcc.org

Abstract
Full Text
Info/History
Metrics
Supplementary material
Data/Code
Preview PDF

Data Availability

All data produced in the present work are contained in the manuscript and in supplementary files.

https://www.aml-risk-model.com/

View the discussion thread.

PreviousNext

Posted March 12, 2022.

Download PDF

Supplementary Material

Data/Code

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Unified classification and risk-stratification in Acute Myeloid Leukemia

Message Subject (Your Name) has forwarded a page to you from medRxiv

Message Body (Your Name) thought you would like to see this page from the medRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Unified classification and risk-stratification in Acute Myeloid Leukemia

Yanis Tazi, Juan E. Arango-Ossa, Yangyu Zhou, Elsa Bernard, Ian Thomas, Amanda Gilkes, Sylvie Freeman, Yoann Pradat, Sean J Johnson, Robert Hills, Richard Dillon, Max F Levine, Daniel Leongamornlert, Adam Butler, Arnold Ganser, Lars Bullinger, Konstanze Döhner, Oliver Ottmann, Richard Adams, Hartmut Döhner, Peter J Campbell, Alan K Burnett, Michael Dennis, Nigel H Russell, Sean M. Devlin, Brian J P Huntly, Elli Papaemmanuil

medRxiv 2022.03.09.22271087; doi: https://doi.org/10.1101/2022.03.09.22271087

Share This Article: